Your browser doesn't support javascript.
loading
Elevated serum alpha-1 antitrypsin is a major component of GlycA-associated risk for future morbidity and mortality.
Ritchie, Scott C; Kettunen, Johannes; Brozynska, Marta; Nath, Artika P; Havulinna, Aki S; Männistö, Satu; Perola, Markus; Salomaa, Veikko; Ala-Korpela, Mika; Abraham, Gad; Würtz, Peter; Inouye, Michael.
Afiliación
  • Ritchie SC; Cambridge Baker Systems Genomics Initiative, Baker Heart & Diabetes Institute, Melbourne, Victoria, Australia.
  • Kettunen J; Cambridge Baker Systems Genomics Initiative, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
  • Brozynska M; Department of Clinical Pathology, The University of Melbourne, Parkville, Victoria, Australia.
  • Nath AP; Computational Medicine, Faculty of Medicine, University of Oulu and Biocenter Oulu, Oulu, Finland.
  • Havulinna AS; National Institute for Health and Welfare, Helsinki, Finland.
  • Männistö S; NMR Metabolomics Laboratory, School of Pharmacy, University of Eastern Finland, Kuopio, Finland.
  • Perola M; Cambridge Baker Systems Genomics Initiative, Baker Heart & Diabetes Institute, Melbourne, Victoria, Australia.
  • Salomaa V; Cambridge Baker Systems Genomics Initiative, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
  • Ala-Korpela M; Cambridge Baker Systems Genomics Initiative, Baker Heart & Diabetes Institute, Melbourne, Victoria, Australia.
  • Abraham G; Cambridge Baker Systems Genomics Initiative, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
  • Würtz P; National Institute for Health and Welfare, Helsinki, Finland.
  • Inouye M; Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland.
PLoS One ; 14(10): e0223692, 2019.
Article en En | MEDLINE | ID: mdl-31644575

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Biomarcadores / Alfa 1-Antitripsina Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2019 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Biomarcadores / Alfa 1-Antitripsina Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2019 Tipo del documento: Article País de afiliación: Australia